Share on StockTwits

Synergy Pharmaceuticals (NASDAQ:SGYP) Insider Kunwar Shailubhai acquired 3,000 shares of Synergy Pharmaceuticals stock in a transaction dated Friday, May 23rd. The shares were purchased at an average price of $3.89 per share, with a total value of $11,670.00. Following the completion of the purchase, the insider now directly owns 91,017 shares in the company, valued at approximately $354,056. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Synergy Pharmaceuticals (NASDAQ:SGYP) opened at 4.42 on Friday. Synergy Pharmaceuticals has a one year low of $3.39 and a one year high of $6.70. The stock has a 50-day moving average of $4.20 and a 200-day moving average of $4.9. The company’s market cap is $414.1 million.

Synergy Pharmaceuticals (NASDAQ:SGYP) last announced its earnings results on Tuesday, May 13th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.05. On average, analysts predict that Synergy Pharmaceuticals will post $-0.86 earnings per share for the current fiscal year.

Separately, analysts at Aegis raised their price target on shares of Synergy Pharmaceuticals to $28.00 in a research note on Monday, March 24th. Four analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus price target of $16.33.

Synergy Pharmaceuticals, Inc is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (NASDAQ:SGYP), disorders and diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.